BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Cardiol. Nov 26, 2026; 18(11): 126754
Published online Nov 26, 2026. doi: 10.4330/wjc.126754
Cardiac comorbidity role in the diagnosis of diabetes mellitus using single lead electrocardiogram utilizing machine learning model
Anna Dmitrievna Karbovskaya, Basheer Abdullah Marzoog, Snezhana Nikolaevna Demchuk, Anastasia Stroeva, Daniil Andreevich Zelenov, Peter Chomakhidze, Natalia Kuznetsova, Syrkin Abromavich, Valentin V Fadeev, Irina V Poluboyarinova, Sevindzh M Ismailova, Philipp Kopylov
Anna Dmitrievna Karbovskaya, State Budgetary Healthcare Institution of the Tver Region, Konakovskaya Central District Hospital, Moscow 11953, Russia
Basheer Abdullah Marzoog, Anastasia Stroeva, Daniil Andreevich Zelenov, Peter Chomakhidze, Natalia Kuznetsova, Philipp Kopylov, Institute of Personalized Cardiology of The Center “Digital Biodesign and Personalized Healthcare” of Biomedical Science and Technology Park, Sechenov First Moscow State Medical University, Moscow 119991, Moskva, Russia
Snezhana Nikolaevna Demchuk, Medical Institute, Federal State Autonomous Educational Institution of Higher Education ‘Belgorod State National Research University’, Belgorod 308015, Belgorodskaya Oblast’, Russia
Syrkin Abromavich, Department of Cardiology, Functional and Ultrasound Diagnostics, Sechenov First Moscow State Medical University, Moscow 119991, Moskva, Russia
Valentin V Fadeev, Irina V Poluboyarinova, Sevindzh M Ismailova, Sechenov First Moscow State Medical University, Moscow 119991, Moskva, Russia
Co-first authors: Anna Dmitrievna Karbovskaya and Basheer Abdullah Marzoog.
Author contributions: Karbovskaya AD and Marzoog BA contributed to writing - original draft, review and editing; Zelenov DA and Marzoog BA contributed to biostatistical analysis; Demchuk SN, Stroeva A, Kuznetsova N, Poluboyarinova IV, Ismailova SM, Chomakhidze P, Fadeev VV, and Abromavich S contributed to data collection; Chomakhidze P, Fadeev VV, Kopylov P, and Abromavich S contributed to concept development; Kopylov P contributed to project supervision. All authors have read and approved the final version of the manuscript.
AI contribution statement: No AI tools were used in the preparation of this manuscript.
Supported by the Application of Mass Spectrometry and Exhaled Air Emission Spectrometry for Cardiovascular Risk Stratification, No. 1023022600020-6; the Priority 2030 Program of the Ministry of Science and Higher Education of Russia, No. 03.000.B.163; and No. 03.000. B. 166.
Institutional review board statement: The study was approved by the Ethics Committee of Sechenov University, Russia (approval No. 19-23, dated: October 26, 2023).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: Applicable on reasonable request from the corresponding author.
Corresponding author: Basheer Abdullah Marzoog, PhD, Senior Researcher, Senior Scientist, Institute of Personalized Cardiology of The Center “Digital Biodesign and Personalized Healthcare” of Biomedical Science and Technology Park, Sechenov First Moscow State Medical University, 8-2 Trubetskaya Street, Moscow 119991, Moskva, Russia. marzug@mail.ru
Received: August 12, 2026
Revised: September 6, 2026
Accepted: November 5, 2026
Published online: November 26, 2026
Processing time: 92 Days and 16.2 Hours
Abstract
BACKGROUND

Cardiovascular disease alters electrocardiographic morphology and may obscure diabetes-related electrical signatures, yet its effect on electrocardiogram (ECG)-based detection of type 1 and type 2 diabetes is poorly defined.

AIM

To investigate whether cardiac comorbidity differentially influences machine-learning detection of the two diabetes types from single-lead ECG.

METHODS

In this study, 2591 observations remained after exclusion of an erroneous age entry and rerunning the analytical pipeline. Twenty-six XGBoost models were evaluated separately for type 1 and type 2 diabetes within subgroups defined by seven cardiac-status criteria. Primary models used 47 single-lead ECG features and five anthropometric variables and were evaluated with five-fold stratified cross-validation. A post hoc seven-predictor sensitivity analysis assessed model complexity. Area under the receiver operating characteristics curve (AUC) uncertainty was estimated using 2000 bootstrap resamples of out-of-fold predictions, and ΔAUC comparisons were adjusted using the Benjamini-Hochberg procedure. Calibration was assessed using Brier score, calibration intercept and slope, reliability plots, and decision-curve analysis. Validation was observation-level because a persistent patient identifier was not available in the analytical export.

RESULTS

After correction and full rerun, median AUC was 0.693 for type 1 diabetes (range: 0.660-0.804) and 0.661 for type 2 diabetes (range: 0.543-0.716). No cardiac-pathology ΔAUC comparison remained statistically significant after Benjamini-Hochberg adjustment; the smallest adjusted P value was 0.064. In the reduced seven-predictor sensitivity analysis, AUC was higher than the 52-predictor model in 17 of 26 evaluable subgroup models, with a median descriptive difference of +0.008. Calibration was suboptimal: Across the 26 models, calibration slopes ranged from 0.078 to 0.467 and intercepts from -1.287 to -0.535. Decision-curve analysis showed threshold-dependent net benefit rather than uniform superiority across the evaluated range.

CONCLUSION

Single-lead ECG combined with anthropometric information showed moderate internal discrimination for recorded diabetes status, but the corrected analysis did not identify a cardiac-pathology subgroup effect that remained significant after multiplicity adjustment. The reduced-feature sensitivity analysis suggested that similar discrimination may be achievable with fewer predictors, whereas calibration remained inadequate for direct interpretation of model outputs as disease probabilities. These findings do not establish a clinically validated screening or rule-out threshold. Patient-grouped validation, independent threshold validation, and external validation remain necessary before clinical implementation.

Keywords: Diabetes mellitus; Single-lead electrocardiography; Machine learning; Cardiovascular disease; Model calibration; Decision-curve analysis

Core Tip: This study demonstrates that single-lead electrocardiography combined with anthropometric variables provides moderate internal discrimination of type 1 and type 2 diabetes mellitus, with median areas under the receiver operating characteristic curve of 0.693 and 0.661, respectively. Although model performance varied across cardiac-comorbidity subgroups, none of these differences remained statistically significant after adjustment for multiple comparisons. A reduced seven-predictor model demonstrated broadly comparable discrimination, suggesting that fewer variables may be sufficient. However, substantial probability miscalibration and threshold-dependent clinical net benefit limit immediate clinical applicability. These findings highlight the potential of electrocardiography-based machine learning while emphasizing the need for patient-level and external validation before clinical implementation.

Write to the Help Desk